INVO Fertility Faces New Nasdaq Delinquency Notice for Late Q1 10-Q Filing
IVF is trading near its 52-week low of $1.38 (8.7% above the low) on elevated volume (2.1× avg).
Summary
INVO Fertility received a Nasdaq notice on May 27 for its late Q1 2026 10-Q filing. The company also confirmed it filed its previously delayed annual 10-K on June 2. This is the second Nasdaq delinquency notice in recent months, following one on April 29 for the late 10-K. The 10-K, filed on June 2, disclosed substantial doubt about the company's ability to continue as a going concern, restated prior financials, and identified material weaknesses. The ongoing failure to meet reporting deadlines, coupled with severe accounting issues and going concern warnings, signals deep operational and financial instability and significantly increases the risk of Nasdaq delisting. The company must file the overdue 10-Q and submit a compliance plan to Nasdaq by June 22.
At the time of this announcement, IVF was trading at $1.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $1.38 to $202.80. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.